Detalles de la búsqueda
1.
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF.
Am Heart J
; 213: 35-46, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31128503
2.
XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis.
Thromb J
; 12: 16, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25093014
3.
Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registry.
Int J Stroke
; 15(3): 308-317, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31847794
4.
Rivaroxaban for venous thromboembolism prevention after major orthopedic surgery: translating trial data into routine clinical practice.
Orthop Res Rev
; 9: 1-11, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-30774472
5.
The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study.
Vasc Health Risk Manag
; 12: 209-18, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27274266
6.
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation.
Ther Clin Risk Manag
; 10: 197-205, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24711702
7.
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk.
Vasc Health Risk Manag
; 10: 101-14, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24648742
Resultados
1 -
7
de 7
1
Próxima >
>>